Affiliation: CHU de Bordeaux
- [Migraine: a disease, not a symptom]Patrick Henry
Département de neurologie Hôpital Pellegrin 33076 Bordeaux
Rev Prat 52:5-7. 2002
- Prevalence and clinical characteristics of migraine in FranceP Henry
Service de Neurologie, Hopital Pellegrin Tripode, Bordeaux, France
Neurology 59:232-7. 2002..To determine the prevalence and clinical features of migraine and related headache types in France...
- Successful treatment of hypnic headache syndrome with acetazolamideIgor Sibon
Group Hospitalier Pellegrin, Service de Neurologie du Professeur Orgogozo, Bordeaux, France
Neurology 61:1157-8. 2003
- Construction of a medication dependence questionnaire in headache patients (MDQ-H) validation of the French versionFrancoise Radat
UTDC, CHU Pellegrin, Bordeaux, France
Headache 46:233-9. 2006..To construct and validate a questionnaire measuring dependence on analgesics and on migraine attack treatments in headache patients...
- Prevalence and description of chronic daily headache in the general population in FranceMichel Lanteri-Minet
Départment d Evaluation et Traitement de la Douleur, Hopital Pasteur, 30, avenue de la Voie Romaine, 06002, Nice Cedex, France
Pain 102:143-9. 2003..Management of this condition is generally inappropriate...
- Usefulness of subcutaneous nitrate for radial accessAnissa Ouadhour
Coronary Care Unit, Department of Cardiology, Lariboisiere Hospital, Assistance Publique Hopitaux de Paris, Paris, France
Catheter Cardiovasc Interv 72:343-6. 2008..We made the hypothesis that adjunction of nitrate to lidocaine for local anesthesia may facilitate accessibility of radial access...
- Sirolimus-eluting versus uncoated stents in acute myocardial infarctionChristian Spaulding
Assistance Publique Hôpitaux de Paris AP HP Cochin Hospital, Paris 5 Medical School Rene Descartes University and INSERM U780, Paris, France
N Engl J Med 355:1093-104. 2006..Data are limited regarding the safety and efficacy of such stents in primary percutaneous coronary intervention (PCI) for acute myocardial infarction with ST-segment elevation...
- Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromesZiad Mallat
Institut National de la Santé et la Recherche Médicale, INSERM U541, Institut Fédératif de Recherche IRF Circulation, Paris, France
J Am Coll Cardiol 46:1249-57. 2005..The purpose of this study was to determine the prognostic value of circulating secretory phospholipase A2 (sPLA2) activity in patients with acute coronary syndromes (ACS)...
- Prognostic significance of renal insufficiency in patients presenting with acute coronary syndrome (the Prospective Multicenter SYCOMORE study)Raphaelle Dumaine
Pitie Salpetriere Hospital, Paris, France
Am J Cardiol 94:1543-7. 2004..One third of patients with ACS presented with renal insufficiency. After adjustment for potential confounders, decreasing renal function was independently associated with in-hospital death, bleeding, and contrast-induced nephropathy...
- Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 studyAndre Pradalier
Hopital Louis Mourier, Colombes, France
Pharmacoeconomics 22:985-99. 2004..The direct annual healthcare costs of migraine in France were assessed over 10 years ago, and the current study updates these figures...
- Impact of headache on quality of life in a general population survey in France (GRIM2000 Study)Gerard Duru
Universite Claude Bernard, Lyon, France
Headache 44:571-80. 2004....
- Impaired fasting glucose, blood pressure and cardiovascular disease mortalityPatrick Henry
Service de cardiologie, Lariboisiere Hospital, Paris, France
Hypertension 40:458-63. 2002..In conclusion, the presence of moderate systolic hypertension can identify subjects with impaired fasting glucose who are at risk of cardiovascular and overall mortality, and vice versa, probably through the metabolic syndrome...
- [Coronary artery disease in diabetic patients]Patrick Henry
Departement de Cardiologie, Hopital Lariboisiere, 75475 Paris Cedex 10, France
Rev Prat 58:1561-4. 2008..After a coronary event, the management of the patient must be as optimal as possible in terms of pharmacological treatment and revascularization. "Ever more" is the key line in these patients...